Article Details
Retrieved on: 2018-05-28 20:22:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Avrobio has filed for an $86.25 million IPO. The offering would give the <b>Atlas</b> <b>Venture</b>-backed startup the means to run clinical trials of gene therapies ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here